Clinical Trial

Guishen Yijing Formula for Diminished Ovarian Reserve: A Real-World Retrospective Study

Study acronym: GSYJ;DOR
Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the real-world effectiveness of Guishen Yijing Formula in women with diminished ovarian reserve (DOR). The main question it aims to answer is: Does Guishen Yijing Formula improve ovarian reserve function in women with DOR after 3 months of treatment? Medical records of participants who received Guishen Yijing Formula as part of their routine clinical care for DOR will be reviewed. Changes in anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), and symptom scores before and after treatment will be analyzed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-16.
Trial Details
NCT Number NCT07660692
Lead Sponsor Shi Yun
Conditions Diminished Ovarian Reserve (DOR)
Enrollment 126 participants
Start Date 2016-04-29
Primary Completion 2025-05-30 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14